NPCE's logo.
Ticker Symbol: NPCE

NeuroPace Inc

$12.45 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001528287

Company Profile

Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy, and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Sector: Manufacturing
Industry: Surgical and Medical Instrument Manufacturing
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
CEO: N/A
Tags: N/A

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $8.41
Change: -$0.64 ( -7.07%)
Days Range: $8.36 - $9.31
Beta: 1.25
52wk. High: $9.73
52wk. Low: $1.22
Ytd. Change 500.31%
50 Day Moving Average: $7.80
200 Day Moving Average: $5.39
Shares Outstanding: 25859643

Valuation

Market Cap: 21.7B
PE Ratio: -
EPS (TTM): -1.69

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A